Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20130713013976N5Phase 3Completed
Phase 3, double-blind trial of desmopressin in chronic rhinosinusitis (CRS) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Amount of blood volume, Visual field of surgery and 1 more. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20130713013976N5.